期刊文献+

阿立哌唑与奥氮平对120例精神分裂症患者催乳素及体质量、血糖、血脂相关影响的对照研究 被引量:14

The correlation clinical study of effect of Arpriazole and Olazpine on serum prolactin,body weight,blood sugar and blood lipid of schizophrenic patients
下载PDF
导出
摘要 目的:探讨阿立哌唑与奥氮平对精神分裂症患者血清催乳素水平、体质量、血糖、血脂等相关因素的影响。方法:将120例精神分裂症患者随机分为研究组(阿立哌唑系统治疗)与对照组(奥氮平系统治疗),共治疗8周,于基线、治疗第4周末和第8周末分别对患者的催乳素、血糖、血脂进行测定。结果:在治疗4周末和8周末研究组患者的催乳素、体质量、血糖、血脂与基线明显升高,差异有统计学意义(P>0.05),对照组患者在第4周末和8周末的催乳素、体质量较基线明显升高,差异有统计学意义(P<0.05)。两组患者的催乳素在第4周末和8周末相比,均具有非常显著的统计学差异(P<0.01)。结论:阿立哌唑对精神分裂症患者的催乳素、体质量无明显影响,而奥氮平对催乳素、体质量有一定影响,两者对血糖、血脂均无明显影响。 Objective:To study the influence of Arpriazole and Olazpine on serum prolactin,body weight,blood sugar and blood lipid of schizophrenic patients.Methods:A total of 120 patients with schizophrenia were randomly divided into study group with Arpriazole and control group with Olazpine for treatment of 8 weeks.They were determined respectively for serum prolactin,body weight,blood sugar and blood lipid in baseline,the 4th weekend and 8th weekend.Results: In the 4th weekend and 8th weekend after treatment,there were no differences for serum prolactin,body weight,blood sugar and blood lipid in study group compared with the baseline.But in the 4th weekend and 8th weekend after treatment,the serum prolacetin and body weight in control group were both significantly higher than those in baseline(P〈0.05).There had significant differences for serum prolactin between two groups in the 4th weekend and 8th weekend(P〈0.05).Conclusions: Arpriazole has no effects on serum prolactin,body weight of patients with schizophrenia,but Olazpine has significant effects on serum prolactin and body weight.Two drugs have no effects on blood sugar and blood lipid.
出处 《中国民康医学》 2011年第11期1317-1319,共3页 Medical Journal of Chinese People’s Health
关键词 催乳素 体质量 血糖 血脂 阿立哌唑 奥氮平 Serum prolactin; Body weight; Blood sugar; Blood lipid; Arpriazole; Olazpine;
  • 相关文献

参考文献13

  • 1Nasrallah HA, Newcomer JW. Atypical antipsychotic and metabolic deregulation: evaluating the risk/benfit equation and improving the standardofcare[J]. Clin Psychopharmacol, 2004, 24 (5 Suppl 1) :7 -14. 被引量:1
  • 2Vohora D. Atypical antipsychotic drugs:current issues of safety and efficacy in the management of schizophrenia[ J ]. Curr Opin Investig Drugs, 2007, 8(7):531 -538. 被引量:1
  • 3Tschoner A. Metabolic side effects of antipsychotic medication [J]. Int J Clin Pract, 2007, 61(8) :1356 -1370. 被引量:1
  • 4Montejo AL. Prolactin awareness: an essential consideration for physical health in schizophrenia[ J ]. Eur Neuropsychopharmacol, 2008, 18(suppl 2) : S108-14. 被引量:1
  • 5Kleninberg DL, Davis JM, de Coster R, et al. Prolactin levels and adverse events in patients treated with risperdone [ J ]. Clin Psychopharmacol, 1999, 19 : 57 - 61. 被引量:1
  • 6Peuskens J. A Literature review of prolactin in schizophrenia[ D]. AstraZenica, 1998, 7. 被引量:1
  • 7Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels [ J ]. Expert Opin Pharmacother, 2002, 3 (10) : 1381 - 1391. 被引量:1
  • 8张向阳,周东丰,沈渔,张培琰,成秀芳,李道,南振国,白京生,石夏明,陈建,张艳萍,管振全.利培酮、氟哌啶醇对血浆泌乳素影响及其与疗效的关系[J].中国心理卫生杂志,2000,14(4):276-278. 被引量:18
  • 9刘朝军,田素英,宋光云,李宝花.齐拉西酮对精神分裂症患者体质量、血糖和泌乳素的影响[J].神经疾病与精神卫生,2009(1):50-52. 被引量:14
  • 10Dossenbach SR, MeQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short- term, placebo - controlled strials [ J ]. Schizophrt Res, 2003,61 : 123. 被引量:1

二级参考文献69

共引文献92

同被引文献117

引证文献14

二级引证文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部